Aggressive Surgical Resection Combined With Imatinib Therapy for Liver Metastases From a Gastrointestinal Stromal Tumor

被引：0

作者：

Tsukagoshi, Mariko ^{[1
]}

Suzuki, Hideki ^{[1
]}

Araki, Kenichiro ^{[1
]}

Ishii, Norihiro ^{[1
]}

Watanabe, Akira ^{[1
]}

Kubo, Norio ^{[1
]}

Wada, Satoshi ^{[1
]}

Saito, Fumiyoshi ^{[1
]}

Kuwano, Hiroyuki ^{[1
]}

机构：

[1] Gunma Univ, Grad Sch Med, Dept Gen Surg Sci, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan

来源：

INTERNATIONAL SURGERY | 2015年 / 100卷 / 9-10期

关键词：

Gastrointestinal stromal tumor; Liver metastasis; Imatinib; Surgical resection;

D O I：

10.9738/INTSURG-D-15-00011.1

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

The use of imatinib mesylate has influenced survival in patients with advanced gastrointestinal stromal tumors (GISTs). However, whether a combination of imatinib and surgical resection can further prolong survival in these patients has not yet been fully elucidated. We report a case of a 59-year-old woman with multiple liver metastases from a jejunal GIST. The patient received imatinib therapy after partial resection of the jejunum, and she subsequently underwent right hepatic trisectionectomy. However, liver metastasis was detected again after surgery. Secondary imatinib therapy was started, and the patient underwent partial hepatectomy at the left lateral segment. Postoperatively, the patient underwent imatinib treatment and has survived without recurrence for 3 years. Imatinib is recommended for the treatment of advanced GIST; however, a complete response is rare, and approximately half of all patients develop resistance to imatinib. Aggressive surgical resection combined with imatinib may be effective for the control of advanced GIST.

引用

页码：1295 / 1300

页数：6

共 19 条

[1] Acquired resistance to imatinib in gastrointestinal stromal tumor occurs through secondary gene mutation [J].

Antonescu, CR ;

Besmer, P ;

Guo, TH ;

Arkun, K ;

Hom, G ;

Koryotowski, B ;

Leversha, MA ;

Jeffrey, PD ;

Desantis, D ;

Singer, S ;

Brennan, MF ;

Maki, RG ;

DeMatteo, RP .

CLINICAL CANCER RESEARCH, 2005, 11 (11) :4182-4190

[2] Consensus meeting for the management of gastrointestinal stromal tumors - Report of the GIST Consensus Conference of 20-21 March 2004, under the auspices of ESMO [J].

Blay, JY ;

Bonvalot, S ;

Casali, P ;

Choi, H ;

Debiec-Richter, M ;

Dei Tos, AP ;

Emile, JF ;

Gronchi, A ;

Hogendoorn, PCW ;

Joensuu, H ;

Le Cesne, A ;

Mac Clure, J ;

Maurel, J ;

Nupponen, N ;

Ray-Coquard, I ;

Reichardt, P ;

Sciot, R ;

Stroobants, S ;

van Glabbeke, M ;

van Oosterom, A ;

Demetri, GD .

ANNALS OF ONCOLOGY, 2005, 16 (04) :566-578

[3] Impact of surgery on advanced gastrointestinal stromal tumors (GIST) in the imatinib era [J].

Bonvalot, S. ;

Eldweny, H. ;

Le Pechoux, C. ;

Vanel, D. ;

Terrier, P. ;

Cavalcanti, A. ;

Robert, C. ;

Lassau, N. ;

Le Cesne, A. .

ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (12) :1596-1603

[4] KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours [J].

Debiec-Rychter, Maria ;

Sciot, Raf ;

Le Cesne, Axel ;

Schlemmer, Marcus ;

Hohenberger, Peter ;

van Oosterom, Allan T. ;

Blay, Jean-Yves ;

Leyvraz, Serge ;

Stul, Michel ;

Casali, Paolo G. ;

Zalcberg, John ;

Verweij, Jaap ;

Van Glabbeke, Martine ;

Hagemeijer, Anne ;

Judson, Ian .

EUROPEAN JOURNAL OF CANCER, 2006, 42 (08) :1093-1103

[5] Results of tyrosine-kinase inhibitor therapy followed by surgical resection for metastatic gastrointestinal stromal tumor [J].

DeMatteo, Ronald P. ;

Maki, Robert G. ;

Singer, Samuel ;

Gonen, Mithat ;

Brennan, Murray F. ;

Antonescu, Cristina R. .

ANNALS OF SURGERY, 2007, 245 (03) :347-352

[6] Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial [J].

DeMatteo, Ronald P. ;

Ballman, Karla V. ;

Antonescu, Cristina R. ;

Maki, Robert G. ;

Pisters, Peter W. T. ;

Demetri, George D. ;

Blackstein, Martin E. ;

Blanke, Charles D. ;

von Mehren, Margaret ;

Brennan, Murray F. ;

Patel, Shreyaskumar ;

McCarter, Martin D. ;

Polikoff, Jonathan A. ;

Tan, Benjamin R. ;

Owzar, Kouros .

LANCET, 2009, 373 (9669) :1097-1104

[7] Two hundred gastrointestinal stromal tumors - Recurrence patterns and prognostic factors for survival [J].

DeMatteo, RP ;

Lewis, JJ ;

Leung, D ;

Mudan, SS ;

Woodruff, JM ;

Brennan, MF .

ANNALS OF SURGERY, 2000, 231 (01) :51-58

[8] Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors [J].

Demetri, GD ;

von Mehren, M ;

Blanke, CD ;

Van den Abbeele, AD ;

Eisenberg, B ;

Roberts, PJ ;

Heinrich, MC ;

Tuveson, DA ;

Singer, S ;

Janicek, M ;

Fletcher, JA ;

Silverman, SG ;

Silberman, SL ;

Capdeville, R ;

Kiese, B ;

Peng, B ;

Dimitrijevic, S ;

Druker, BJ ;

Corless, C ;

Fletcher, CDM ;

Joensuu, H .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) :472-480

[9] Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial [J].

Demetri, George D. ;

van Oosterom, Allan T. ;

Garrett, Christopher R. ;

Blackstein, Martin E. ;

Shah, Manisha H. ;

Verweij, Jaap ;

McArthur, Grant ;

Judson, Ian R. ;

Heinrich, Michael C. ;

Morgan, Jeffrey A. ;

Desai, Jayesh ;

D Fletcher, Christopher ;

George, Suzanne ;

Bello, Carlo L. ;

Huang, Xin ;

Baum, Charles M. ;

Casali, Paolo G. .

LANCET, 2006, 368 (9544) :1329-1338

[10] Surgery and imatinib in the management of GIST: Emerging approaches to adjuvant and neoadjuvant therapy [J].

Eisenberg, BL ;

Judson, I .

ANNALS OF SURGICAL ONCOLOGY, 2004, 11 (05) :465-475

← 1 2 →